Idiotype, anti-idiotype network of autoantibodies. Pathogenetic considerations and clinical application

Autoimmunity Reviews

Volumn 9, Issue 9, 2010, Pages 631-633

  Tzioufas, Athanasios G ^a   Routsias, John G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Anti idiotypic antibodies; Anti La SSB; Autoantibodies; B cell epitopes; Complementary epitopes; Neonatal lupus; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN IDIOTYPE; LA ANTIBODY; RO ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; B LYMPHOCYTE; DISEASE PREDISPOSITION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LUPUS ERYTHEMATOSUS; MOLECULAR RECOGNITION; NEWBORN DISEASE; NONHUMAN; PROTEIN FUNCTION; REVIEW;

ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; EPITOPES; HUMANS; IMMUNOGLOBULIN IDIOTYPES; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 77954383991     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.05.013     Document Type: Review

References (30)

1. Routsias J.G., Vlachoyiannopoulos P.G., Tzioufas A.G. Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. Crit Rev Clin Lab Sci 2006, 43:203-248.
2. Tzioufas A.G., Wassmuth R., Dafni U.G., Guialis A., Haga H.J., Isenberg D.A., et al. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study. Ann Rheum Dis 2002, 61:398-404.
3. Yiannaki E., Vlachoyiannopoulos P.G., Manoussakis M.N., Sakarellos C., Sakarellos-Daitsiotis M., Moutsopoulos H.M., et al. Study of antibody and T cell responses in rabbits immunized with synthetic human B cell epitope analogues of La (SSB) autoantigen. Clin Exp Immunol 2000, 121:551-556.
4. Routsias J.G., Kyriakidis N., Latreille M., Tzioufas A.G. RNA recognition motif (RRM) of La/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP. Mol Med 2010, 16:19-26.
5. Tzioufas A.G., Hantoumi I., Polihronis M., Xanthou G., Moutsopoulos H.M. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs). J Autoimmun 1999, 13:429-434.
6. Tengnér P., Halse A.K., Haga H.J., Jonsson R., Wahren-Herlenius M. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum 1998, 41:2238-2248.
7. Jerne N.K. Towards a network theory of the immune system. Ann Immunol (Paris) 1974, 125C:373-389.
8. Plotz P.H. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 1983, 2:824-826.
9. Abdou N.I., Wall H., Lindsley H.B., Halsey J.F., Suzuki T. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J Clin Invest 1981, 67:1297-1304.
10. Zhou Z.H., Tzioufas A.G., Notkins A.L. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 2007, 29:219-228.
11. Blalock J.E. Complementarity of peptides specified by 'sense' and 'antisense' strands of DNA. Trends Biotechnol 1990, 8:140-144.
12. Weathington N.M., Blalock J.E. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network. Expert Rev Vaccin 2003, 2:61-73.
13. Routsias J.G., Touloupi E., Dotsika E., Moulia A., Tsikaris V., Sakarellos C., et al. Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol Med 2002, 8:293-305.
14. Routsias J.G., Dotsika E., Touloupi E., Papamattheou M., Sakarellos C., Sakarellos-Daitsiotis M., et al. Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. J Autoimmun 2003, 21:17-26.
15. Pendergraft W.F., Preston G.A., Shah R.R., Tropsha A., Carter C.W., Jennette J.C., et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004, 10:72-79.
16. Pendergraft W.F., Pressler B.M., Jennette J.C., Falk R.J., Preston G.A. Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease. J Mol Med 2005, 83:12-25.
17. Buyon J.P., Hiebert R., Copel J., Craft J., Friedman D., Katholi M., et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998, 31:1658-1666.
18. Boh E.E. Neonatal lupus erythematosus. Clin Dermatol 2004, 22:125-128.
19. Brucato A., Frassi M., Franceschini F., Cimaz R., Faden D., Pisoni M.P., et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001, 44:1832-1835.
20. Gordon P., Khamashta M.A., Rosenthal E., Simpson J.M., Sharland G., Brucato A., et al. Anti-52kDa Ro, anti-60kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol 2004, 31:2480-2487.
21. Buyon J.P., Clancy R.M. Autoantibody-associated congenital heart block: TGFbeta and the road to scar. Autoimmun Rev 2005, 4:1-7.
22. Blalock J.E., Whitaker J.N., Benveniste E.N., Bost K.L. Use of peptides encoded by complementary RNA for generating anti-idiotypic antibodies of predefined specificity. Meth Enzymol 1989, 178:63-74.
23. Horsfall A.C., Venables P.J., Taylor P.V., Maini R.N. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 1991, 4:165-176.
24. Stea E.A., Routsias J.G., Clancy R.M., Buyon J.P., Moutsopoulos H.M., Tzioufas A.G. Anti-LA/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum 2006, 54:2228-2234.
25. Tzioufas A.G., Yiannaki E., Sakarellos-Daitsiotis M., Routsias J.G., Sakarellos C., Moutsopoulos H.M. Fine specificity of autoantibodies to La/SSB: epitope mapping, and characterization. Clin Exp Immunol 1997, 108:191-198.
26. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347:151-156.
27. Falorni A., Brozzetti A. Diabetes-related antibodies in adult diabetic patients. Best Pract Res Clin Endocrinol Metab 2005, 19:119-133.
28. Solimena M., De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in Stiff-Man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci 1991, 14:452-457.
29. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996, 45:926-933.
30. Oak S., Gilliam L.K., Landin-Olsson M., Torn C., Kockum I., Pennington C.R., et al. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc Natl Acad Sci U S A 2008, 105:5471-5476.